BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹241 Cr | ₹336 Cr | ₹279 Cr | ₹231 Cr | ₹46 Cr |
What is the latest Revenue of BALAXI PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹336 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹231 Cr |
| Mar2021 | ₹46 Cr |
How is Revenue of BALAXI PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -28.28 | |
| Mar2024 | ₹336 Cr | 20.42 | |
| Mar2023 | ₹279 Cr | 20.77 | |
| Mar2022 | ₹231 Cr | 406.94 | |
| Mar2021 | ₹46 Cr | - | |
Compare Revenue of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹108.9 Cr | -2.9% | -19.1% | -64.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹279,840.0 Cr | -1.1% | 7.2% | 7% | Stock Analytics | |
| REDINGTON | ₹21,948.3 Cr | 14.3% | 3.3% | -2.7% | Stock Analytics | |
| HONASA CONSUMER | ₹9,862.0 Cr | -1.3% | 9.7% | 37.3% | Stock Analytics | |
| MMTC | ₹9,292.5 Cr | 0.7% | -4.8% | 9.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,808.3 Cr | -4.1% | -12.1% | 16.6% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.9% |
-19.1% |
-64.8% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses